questionText: To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that guidance to primary care clinicians on screening for prostate cancer includes reference to the potential impact of the BRCA2 gene variation on risk levels.
answerText: The Prostate Cancer Risk Management Programme provides guidance for general practitioners on how to counsel men who have no symptoms but wish to have a Prostate Specific Antigen (PSA) test for prostate cancer. It highlights the potential benefits and harm...
heading: Prostate Cancer: Screening